chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Chills, Cough, Dizziness, Paraesthesia
Clinical narrative: mild chest pressure/tightness; chills; slight cough; Within 5 min after shot I had mild dizziness/30min later I experienced moderate to severe dizziness/feeling faint; left hand tingling which subsided/tingling of hands and feet; This is a spontaneous report from a contactable consumer (patient). A 34-years-old female patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in arm left on 19Dec2020 19:30 at single dose for COVID-19 immunization. Medical history included eczema. There were no allergies to medications, food, or other products. Concomitant medication included patch birth control within 2 weeks of vaccination. Within 5 min (19Dec2020 19:35) after shot the patient had mild dizziness with left hand tingling which subsided. Then 30min later (19Dec2020 20:00) the patient experienced moderate to severe dizziness, feeling faint, tingling of hands and feet, mild chest pressure/tightness, chills, and slight cough. The feeling lasted about 1 hr. Chest tightness resolved after taking Benadryl. No treatment received for other events. The patient was no pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The events were reported as non-serious. The outcome of the events was recovered in Dec2020.  Information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Nasal congestion
Clinical narrative: moderate pain at injection site; congested nose; This is a spontaneous report from a non-contactable consumer (patient's husband). A female patient (frontline health care professional)  received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on Dec2020 as a single dose for COVID-19 vaccination. The patient medical history and concomitant medications were not reported.  On Dec2020,  the patient experienced moderate pain at injection site and congested nose. In Dec2020, the pain was mild around the injection site and  her congested nose was now clear. The clinical outcome of the moderate pain at injection was recovering and the outcome of the event congested nose was recovered Dec2020.   No follow-up attempts are possible; information about lot number cannot be obtained.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature increased, Nasal congestion
Clinical narrative: Temp 99.6 and congestion.; Temp 99.6 and congestion.; This is a spontaneous report from a non-contactable nurse. A 24-year-old female patient received first dose of BNT162B2, intramuscularly on 18Dec2020 08:00 at a single dose for COVID 19 immunization. The patient medical history was not reported. The patient is not a pregnant at the time of vaccination. Concomitant medication included sertraline hydrochloride (ZOLOFT), ethinylestradiol, ferrous fumarate, norethisterone acetate (TAYTULLA). The patient experienced temp 99.6 and congestion, both on 18Dec2020. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No treatment was received for the adverse event. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. This is a non-serious report. The outcome of events was not recovered.    No follow-up attempts are possible, information about lot/batch number cannot be obtained.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Chills, Headache, Injection site pain
Clinical narrative: Muscle pain; Joint pain; Sore throat; Feeling unwell; stated she feels very weak; stated she had initially had a fever of 102 degrees Fahrenheit, and now has a fever of 100 degrees Fahrenheit; Chills; injection site soreness; Headache; This is a spontaneous report from a contactable consumer. A 60-year-old female patient received the first dose of bnt162b2 (BNT162B2, lot number: EK5730), via an unspecified route of administration on 17Dec2020 09:30 on the right upper shoulder at single dose for immunization. Medical history included stomach cancer over 20 years ago, clarifying she no longer has stomach cancer. The patient's concomitant medications were not reported. On 17Dec2020, the patient experienced injection site soreness, headache, chills, she initially had a fever of 102 degrees Fahrenheit and now has a fever of 100 degrees Fahrenheit. Yesterday evening (17Dec2020) she developed a fever with chills, saying she couldn't get warm, so she went to bed. She said when she got up this morning (18Dec2020), she had the other side effects: muscle pain, chills, joint pain, sore throat, feeling unwell, and she feels very weak. Reported she couldn't function when she woke up this morning. For the treatment of headache, the patient took 1 Ibuprofen 600mg tablet. She said she still has a headache, but her headache has improved. She said she took an over-the-counter Tylenol 500mg tablet. She received the COVID-19 shot at the hospital she is employed. The reported events did not require a visit to Emergency Room and Physician Office. The events headache, muscle pain, chills, joint pain, fever, sore throat was recovering, and the outcome of the remaining events was not recovered.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Myalgia, Oropharyngeal pain, Pyrexia
Clinical narrative: Muscle pain; Joint pain; Sore throat; Feeling unwell; stated she feels very weak; stated she had initially had a fever of 102 degrees Fahrenheit, and now has a fever of 100 degrees Fahrenheit; Chills; injection site soreness; Headache; This is a spontaneous report from a contactable consumer. A 60-year-old female patient received the first dose of bnt162b2 (BNT162B2, lot number: EK5730), via an unspecified route of administration on 17Dec2020 09:30 on the right upper shoulder at single dose for immunization. Medical history included stomach cancer over 20 years ago, clarifying she no longer has stomach cancer. The patient's concomitant medications were not reported. On 17Dec2020, the patient experienced injection site soreness, headache, chills, she initially had a fever of 102 degrees Fahrenheit and now has a fever of 100 degrees Fahrenheit. Yesterday evening (17Dec2020) she developed a fever with chills, saying she couldn't get warm, so she went to bed. She said when she got up this morning (18Dec2020), she had the other side effects: muscle pain, chills, joint pain, sore throat, feeling unwell, and she feels very weak. Reported she couldn't function when she woke up this morning. For the treatment of headache, the patient took 1 Ibuprofen 600mg tablet. She said she still has a headache, but her headache has improved. She said she took an over-the-counter Tylenol 500mg tablet. She received the COVID-19 shot at the hospital she is employed. The reported events did not require a visit to Emergency Room and Physician Office. The events headache, muscle pain, chills, joint pain, fever, sore throat was recovering, and the outcome of the remaining events was not recovered.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Swollen Lymph Nodes; This is a spontaneous report from a contactable nurse (patient himself). A 39-year-old male patient received first dose of bnt162b2, intramuscularly at site of left arm at 12:00 on 17Dec2020 at single dose for COVID-19 immunization. Medical history included COVID-19. There were no concomitant medications. The patient experienced swollen lymph nodes at 09:00 on 19Dec2020. No treatment received for the adverse event. Prior to vaccination, patient diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The outcome of event was recovering.  Information on the lot/batch number has been requested.
Sex: U
Vaccine: PNC13
Symptoms: Palpitations, Swelling
Clinical narrative: allergies/was pneumococcal vaccine; swelling; This is a spontaneous report from a contactable physician. An adult patient of an unspecified age and gender received pneumococcal 13-valent conjugate vaccine (diphtheria CRM197 protein) via an unspecified route of administration on an unspecified date at a single dose for immunization. Medical history and concomitant medications were not reported. The patient previously had reactions to hydrochlorothiazide w-triamterene noted on 19Sep2014 as palpitations and was noted as allergies as of 19Nov2020. It was noted that allergies as of 19Nov2020 was pneumococcal vaccine; noted on 19Sep2014 was reactions: swelling on unspecified dates. The outcome of the events was unknown.  No follow up attempts are needed. Information about lot/batch number cannot been obtained. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Myalgia, Nausea
Clinical narrative: Fever; Chills; muscle aches; Fatigue; Joint pain; nausea; vomiting; This is a spontaneous report from a contactable nurse (patient herself). A 33-year-old female patient (no pregnancy) received first dose of bnt162b2, intramuscularly at site of left arm at 10:00 on 18Dec2020 at single dose for COVID-19 immunization. Medical history reported none. Concomitant medication included iron, cyanocobalamin, pyridoxine hydrochloride, thiamine hydrochloride (VITAMIN B 1-6-12) (reported as vitamin B supplement) and birth control pills. The patient experienced fever, chills, muscle aches, fatigue, joint pain, nausea and vomiting at 21:00 on 18Dec2020. The outcome of events was recovering.  Information on Lot/Batch number has been requested.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vomiting
Clinical narrative: Fever; Chills; muscle aches; Fatigue; Joint pain; nausea; vomiting; This is a spontaneous report from a contactable nurse (patient herself). A 33-year-old female patient (no pregnancy) received first dose of bnt162b2, intramuscularly at site of left arm at 10:00 on 18Dec2020 at single dose for COVID-19 immunization. Medical history reported none. Concomitant medication included iron, cyanocobalamin, pyridoxine hydrochloride, thiamine hydrochloride (VITAMIN B 1-6-12) (reported as vitamin B supplement) and birth control pills. The patient experienced fever, chills, muscle aches, fatigue, joint pain, nausea and vomiting at 21:00 on 18Dec2020. The outcome of events was recovering.  Information on Lot/Batch number has been requested.
Sex: U
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Patient experienced sore arm following COVID vaccine; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received bnt162b2, via an unspecified route of administration in 2020 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced sore arm following COVID vaccine in 2020. The outcome of event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature increased, Pyrexia
Clinical narrative: fever/Her body is very hot (99.8F); This is a spontaneous report from a contactable consumer.   A female patient (mother of the reporter) of an unspecified age receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 18Dec2020 at single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient woke up with fever on 19Dec2020 with outcome of unknown. Her body was very hot. The temperature was 99.8F.  Information about lot/batch number has been requested.
Sex: U
Vaccine: COVID19
Symptoms: Fatigue, Headache, Injection site pain
Clinical narrative: injection site pain; Feeling more tired than usual the day off and after; headache; This is a spontaneous report from a contactable consumer. A patient of an unspecified age and gender (reported as the front-line physician) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, batch/lot number: unknown), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that the patient got COVID-19 vaccine and reported some injection site pain, feeling more tired than usual the day off and after. The patient also mentioned having a headache on an unspecified date. The outcome of events was unknown.   No follow-up attempts are possible. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Itching hands, feet, to arms, legs, scalp, inside ears, Benadryl 25 mg Qhs
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure increased, Diarrhoea, Fatigue, Flushing, Headache
Clinical narrative: 1245: Patient vitals taken, BP 169/122, HR107, 02 SAT 98%, Temp 98.4. Patient advised he no longer has the headache but still feels flushed . 1257: vitals taken again BP 167/122, HR 101, O2 SAT 98%. Patient also advised he was having GI upset (diarrhea). Dr. monitoring patient with this RN, aware of patient vitals, Allegra 80mg PO given at 1300 by CNO per protocol.  1315: BP 172/116, HR 108, O2SAT  98%. Dr. has advised patient to log BP's at home and that he may have underlying hypertension. Dr. has advised patient that he will be called for a follow-up appointment tomorrow with a physician.  1326: BP 174/104, HR 103, O2 sat 99%. Patient states he is now felling back to normal, denied headache and flushing at this time. Dr. had given the patient clearance to return to work at this time. Advised patient that if he starts to have any s/s again to go to Urgent Care or ER. RN will follow-up with Caregiver.  1537: Spoke to patient states he currently had a mild headache and is fatigued. States he left work an hour early and is going to go home and rest.  1547: Spoke with Dr., MD advised for Caregiver to be seen at Urgent Care today for follow-up. Patient states he feels ok to drive and will make his way to Urgent Care now.  1653: Patient called RN back, states he is feeling better and declines going to urgent care at this time. He advised his headache and fatigue is resolved, stating "I only have mild soreness at injection site." Patient states he will go to Urgent Care tomorrow for a follow-up. RN will follow-up with Caregiver tomorrow.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: 1245: Patient vitals taken, BP 169/122, HR107, 02 SAT 98%, Temp 98.4. Patient advised he no longer has the headache but still feels flushed . 1257: vitals taken again BP 167/122, HR 101, O2 SAT 98%. Patient also advised he was having GI upset (diarrhea). Dr. monitoring patient with this RN, aware of patient vitals, Allegra 80mg PO given at 1300 by CNO per protocol.  1315: BP 172/116, HR 108, O2SAT  98%. Dr. has advised patient to log BP's at home and that he may have underlying hypertension. Dr. has advised patient that he will be called for a follow-up appointment tomorrow with a physician.  1326: BP 174/104, HR 103, O2 sat 99%. Patient states he is now felling back to normal, denied headache and flushing at this time. Dr. had given the patient clearance to return to work at this time. Advised patient that if he starts to have any s/s again to go to Urgent Care or ER. RN will follow-up with Caregiver.  1537: Spoke to patient states he currently had a mild headache and is fatigued. States he left work an hour early and is going to go home and rest.  1547: Spoke with Dr., MD advised for Caregiver to be seen at Urgent Care today for follow-up. Patient states he feels ok to drive and will make his way to Urgent Care now.  1653: Patient called RN back, states he is feeling better and declines going to urgent care at this time. He advised his headache and fatigue is resolved, stating "I only have mild soreness at injection site." Patient states he will go to Urgent Care tomorrow for a follow-up. RN will follow-up with Caregiver tomorrow.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Immediate post-injection reaction, Injection site induration, Injection site pain
Clinical narrative: Immediate pain in right arm with administration of vaccine. 30 mins after administration noticed shooting pain in to elbow. Shooting pain has continued through today. Also reports palm sized hardness at injection site.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature increased, Cough, Fatigue, Gaze palsy, Injection site pain
Clinical narrative: Mild headache, mild fatigue, dry non productive cough, soreness in injection site, and 100.6 °F temperature.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Injection site pain
Clinical narrative: chills; pain at the injection site; This is a spontaneous report from a contactable consumer, the patient. A female patient  received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on 17Dec2020  in the as a single dose for COVID-19 vaccination. The patient medical history and concomitant medications were not reported.  On Dec2020 the patient experienced chills and pain at the injection site. The clinical outcome of the chills and pain at injection site was unknown.   Information regarding lot number has been requested.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Hallucination, Headache, Pain in extremity, Pyrexia
Clinical narrative: 12 hours after receiving vaccine patient experienced pain in right arm, headache, fever (did not have working thermometer to check her temperature), chills and hallucinations.  Symptoms persisted for 36 hours.  She did not report symptoms until they had resolved.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Hallucination, Headache, Laboratory test, Pain in extremity
Clinical narrative: 12 hours after receiving vaccine patient experienced pain in right arm, headache, fever (did not have working thermometer to check her temperature), chills and hallucinations.  Symptoms persisted for 36 hours.  She did not report symptoms until they had resolved.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia
Clinical narrative: 12 hours after receiving vaccine patient experienced pain in right arm, headache, fever (did not have working thermometer to check her temperature), chills and hallucinations.  Symptoms persisted for 36 hours.  She did not report symptoms until they had resolved.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Pyrexia
Clinical narrative: Fever at 102 to 103. Chills and shivering
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Lip oedema, Paraesthesia oral, Pharyngeal paraesthesia
Clinical narrative: Tingling in lips and throat, sensation of swelling in lips, not visible, that started 25 min. after the vaccination and lasted about 2 min.
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal
Clinical narrative: feeling similar to a slight hangover; This is a spontaneous report from a contactable consumer and a non-contactable consumer.  These two consumers reported for a female patient of an unspecified age who received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE),  via an unspecified route of administration on 17Dec2020 as a single dose for COVID-19 vaccination.  The patient's medical history and concomitant medications were not reported.  The patient experienced feeling similar to a slight hangover on 18Dec2020. The clinical outcome of feeling similar to a slight hangover was unknown.  The lot number for the vaccine, VACCINE BNT162B2, was not provided and will be requested during follow up.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Dizziness, Nausea, Rash erythematous, Rash macular
Clinical narrative: Lightheadedness, blurry vision, dizziness, chest tightness, nausea, red splotchy rash Pt was treated with benadryl and pepcid by mouth and Solumedrol IM. Pt's symptoms lasted 90 minutes.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Vision blurred
Clinical narrative: Lightheadedness, blurry vision, dizziness, chest tightness, nausea, red splotchy rash Pt was treated with benadryl and pepcid by mouth and Solumedrol IM. Pt's symptoms lasted 90 minutes.
Sex: U
Vaccine: COVID19
Symptoms: Flushing, Pain in extremity, Pyrexia
Clinical narrative: Sore arm; Mild fever; Flushing; This is a spontaneous report from a non-contactable Other-HCP via Pfizer sales representative. A patient of unspecified age and gender received BNT162B2 (Pfizer-BioNTech COVID-19 vaccine) via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was unknown whether the patient received any other vaccine within 4 weeks prior to the vaccine. On an unspecified date, the patient experienced sore arm, mild fever and flushing after use of the product. Clinical outcome of the  sore arm, mild fever and flushing was unknown.     No follow-up attempts are possible. Information about batch number cannot be obtained.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Flushing, Headache, Muscle tightness, Rash
Clinical narrative: Patient started experiencing dizziness, flushing and rash. Vital signs obtained at 10:19, patient was feeling better and less dizzy, slight HA, swallowing fine. BP 166/57; HR 79; Temp 99.4. At 10:20 temp was 99.7. 650 mg of APAP given po at 10:22. At 10:30, patient c/o tension across shoulders, no c/o pain or pressure. At 10:32 dizziness improving with BP 167/63; O2 sats at 100%; HR 70, Temp 99.3. Benadryl 25 mg po given at 10:25. 10:47 O2 sats 100%; HR 72; BP 152/64.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Eye swelling, Pharyngeal swelling
Clinical narrative: EYE AND THROAT SWELLING
Sex: F
Vaccine: COVID19
Symptoms: Flushing, Pruritus, Rash, Rash erythematous
Clinical narrative: flushing of face; chest arms with slight red rash slight itch; chest arms with slight red rash slight itch; This is a spontaneous report from a contactable consumer (patient) via Pfizer Sales Representative. A female patient of unspecified age (age:33, units: unknown) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 18Dec2020 19:30 at single dose for COVID-19 immunization. The relevant medical history included idiopathic urticaria. Concomitant medications were not reported. After administration of vaccine, the patient experienced flushing of face, chest arms with slight red rash, slight itch in Dec2020. Events took place after use of product. She was given Benadryl and held in Emerge-department for 90 minutes until symptoms were better. The outcome of the events was recovering.  Information about Lot/Batch number has been requested.
Age: 72.0
Sex: F
Vaccine: VARZOS
Symptoms: Asthenia, Dysstasia, Feeling abnormal, Gait inability, Hyperhidrosis
Clinical narrative: After 12 hours of receiving 1st dose of Shingrix vaccine, patient woke up out of sleep, feeling bad. She walked to restroom and fainted, loss consciousness. When she came to, patient felt weak, and could not walk or stand up. After 30 minutes, patient started to sweat badly. Sweat beading off of body. After sweating stopped, patient was back to normal (which was approximately one hour after losing  consciousness).
Age: 72.0
Sex: F
Vaccine: VARZOS
Symptoms: Loss of consciousness, Sleep disorder, Syncope
Clinical narrative: After 12 hours of receiving 1st dose of Shingrix vaccine, patient woke up out of sleep, feeling bad. She walked to restroom and fainted, loss consciousness. When she came to, patient felt weak, and could not walk or stand up. After 30 minutes, patient started to sweat badly. Sweat beading off of body. After sweating stopped, patient was back to normal (which was approximately one hour after losing  consciousness).
Sex: M
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: aches; This is a spontaneous report from contactable nurse via Pfizer Sales Representative. A 53-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), the first dose via an unspecified route of administration on an unspecified date at single dose for immunization. The patient's medical history and concomitant medications were not reported. One day after receiving the first dose of the COVID vaccine the patient experienced aches. Outcome of event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Chest X-ray, Computerised tomogram, Dizziness, Electrocardiogram, Fatigue
Clinical narrative: Severe dizziness and nausea 3 days after vaccine with fatigue for approximately 24 hours
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Laboratory test, Nausea
Clinical narrative: Severe dizziness and nausea 3 days after vaccine with fatigue for approximately 24 hours
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Paraesthesia
Clinical narrative: Pfizer-BioNTech COVID-19 Vaccine EUA  metallic taste in mouth, tingling in hand
Sex: U
Vaccine: COVID19
Symptoms: Headache, Pain in extremity
Clinical narrative: Reported arm soreness and headache after being administered the COVID 19 vaccine; Reported arm soreness and headache after being administered the COVID 19 vaccine; This is a spontaneous report from a non-contactable Physician via Pfizer sales representative. A patient of unspecified age and gender received BNT162B2 (Pfizer-BioNTech COVID-19 vaccine) via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was unknown whether the patient received any other vaccine within 4 weeks prior to the vaccine. On an unspecified date, the patient experienced arm soreness and headache after being administered the vaccine. Clinical outcome of the arm soreness and headache was unknown.     No follow-up attempts are possible. Information about batch number cannot be obtained.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Hypertension, Tachycardia
Clinical narrative: I was tachycardic and hypertensive.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia
Clinical narrative: Metallic taste in mouth, started shortly after vaccine administration (during 15 min waiting time after administration). Persisted for approx 24 hours.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anxiety, Dizziness, Oxygen saturation normal, Respiratory rate increased
Clinical narrative: Progress Notes APRN (Nurse Practitioner) ? ? Nurse Practitioner Cosign Needed Expand All Collapse All    COVID VACCINE CLINIC 12/22/2020    Patient:                                                               Date:  12/22/2020                                                                                             Subjective Patient is a 34 y.o. female who was seen at COVID Vaccine Clinic today for her first dose of the COVID 19 vaccination.    She denied any history of previous adverse reactions to vaccines.   She was given the Pfizer vaccination in the left deltoid muscle.   During her 15 minute waiting period after the injection, the patient began to experience dizziness.  She denied rash, hives, welts, difficulty breathing, difficulty swallowing, wheezing, throat tightness, hoarseness, stridor, itching, facial swelling, lip swelling and tongue swelling.   This provider was notified of patient reaction and she was then assessed in the emergency bay area.   Pt has history of anxiety and takes Hydralazine prn.  She presents with rapid breathing and anxiety.     Monitored patient for severe reaction symptoms, including respiratory distress with stridor, wheezing, dyspnea, increased work of breathing, persistent cough and cyanosis.       Review of Systems  Neurological: Positive for dizziness and light-headedness.  All other systems reviewed and are negative.        Objective    Vitals Vitals:   12/22/20 1425 12/22/20 1428 12/22/20 1434 BP: (!) 141/119 122/84 121/73 BP Location: Right arm Right arm Right arm Patient Position: Sitting Sitting Sitting Pulse: (!) 134 (!) 109 92 SpO2: 97% 98% 98%     Physical Exam Vitals signs reviewed.  HENT:     Head: Normocephalic.     Nose: Nose normal.     Mouth/Throat:     Mouth: Mucous membranes are moist.  Eyes:     Pupils: Pupils are equal, round, and reactive to light.  Neck:     Musculoskeletal: Normal range of motion.  Cardiovascular:     Rate and Rhythm: Normal rate and regular rhythm.     Pulses: Normal pulses.  Musculoskeletal: Normal range of motion.  Skin:    Capillary Refill: Capillary refill takes less than 2 seconds.  Neurological:     General: No focal deficit present.     Mental Status: She is alert and oriented to person, place, and time.  Psychiatric:        Mood and Affect: Mood normal.        Behavior: Behavior normal.         Assessment/Plan  Treatment included: no therapy. Follow up response to treatment: no side effects. Patient discharge: Stable to go home and follow up with PCP.   Pt's breathing slowed and felt less anxious by the time she left.        APRN Electronically Signed 12/22/2020 2:36 PM
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anxiety, Condition aggravated, Dizziness, Respiratory rate increased
Clinical narrative: Progress Notes APRN (Nurse Practitioner) ? ? Nurse Practitioner Cosign Needed Expand All Collapse All    COVID VACCINE CLINIC 12/22/2020    Patient:                                                               Date:  12/22/2020                                                                                             Subjective Patient is a 34 y.o. female who was seen at COVID Vaccine Clinic today for her first dose of the COVID 19 vaccination.    She denied any history of previous adverse reactions to vaccines.   She was given the Pfizer vaccination in the left deltoid muscle.   During her 15 minute waiting period after the injection, the patient began to experience dizziness.  She denied rash, hives, welts, difficulty breathing, difficulty swallowing, wheezing, throat tightness, hoarseness, stridor, itching, facial swelling, lip swelling and tongue swelling.   This provider was notified of patient reaction and she was then assessed in the emergency bay area.   Pt has history of anxiety and takes Hydralazine prn.  She presents with rapid breathing and anxiety.     Monitored patient for severe reaction symptoms, including respiratory distress with stridor, wheezing, dyspnea, increased work of breathing, persistent cough and cyanosis.       Review of Systems  Neurological: Positive for dizziness and light-headedness.  All other systems reviewed and are negative.        Objective    Vitals Vitals:   12/22/20 1425 12/22/20 1428 12/22/20 1434 BP: (!) 141/119 122/84 121/73 BP Location: Right arm Right arm Right arm Patient Position: Sitting Sitting Sitting Pulse: (!) 134 (!) 109 92 SpO2: 97% 98% 98%     Physical Exam Vitals signs reviewed.  HENT:     Head: Normocephalic.     Nose: Nose normal.     Mouth/Throat:     Mouth: Mucous membranes are moist.  Eyes:     Pupils: Pupils are equal, round, and reactive to light.  Neck:     Musculoskeletal: Normal range of motion.  Cardiovascular:     Rate and Rhythm: Normal rate and regular rhythm.     Pulses: Normal pulses.  Musculoskeletal: Normal range of motion.  Skin:    Capillary Refill: Capillary refill takes less than 2 seconds.  Neurological:     General: No focal deficit present.     Mental Status: She is alert and oriented to person, place, and time.  Psychiatric:        Mood and Affect: Mood normal.        Behavior: Behavior normal.         Assessment/Plan  Treatment included: no therapy. Follow up response to treatment: no side effects. Patient discharge: Stable to go home and follow up with PCP.   Pt's breathing slowed and felt less anxious by the time she left.        APRN Electronically Signed 12/22/2020 2:36 PM
Sex: U
Vaccine: COVID19
Symptoms: Dysgeusia
Clinical narrative: metallic taste; This is a spontaneous report from a contactable nurse.  This nurse reported similar events for two patients.  This is the first of two reports.  A patient of unspecified age and gender received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration, in Dec2020 at a single dose for COVID-19 immunization.  The patient's medical history and concomitant medications were not reported.  The patient experienced metallic taste in Dec2020.  The clinical outcome of metallic taste was unknown.    The batch/lot number for the vaccine, BNT162B2, was not provided and will be requested during follow-up.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2020504716 same reporter/drug/event, different patient
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pyrexia
Clinical narrative: Severe headache and fever up to 100.4 no treatment, resolved on own in a few hours
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Cough, Dysphonia, Paraesthesia oral, Tremor
Clinical narrative: at 7 minutes after vaccine administered, reported feeling shaky and lips tingly, anxiety.  Did not immediately notify monitoring staff thinking she was anxious, by 10 minutes after started to experience some coughs and felt voice changed, Epinephrine administered via EpiPen at 13 minutes post vaccination with immediate relief.  No visible hives or swelling.
Sex: U
Vaccine: COVID19
Symptoms: Dysgeusia
Clinical narrative: metallic taste; This is a spontaneous report from a contactable nurse.  This nurse reported similar events for two patients.  This is the second of two reports.  A patient of unspecified age and gender received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration, in Dec2020 at a single dose for COVID-19 immunization.  The patient's medical history and concomitant medications were not reported.  The patient experienced metallic taste in Dec2020.  The clinical outcome of metallic taste was unknown.    The batch/lot number for the vaccine, BNT162B2, was not provided and will be requested during follow-up.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2020504715 same reporter/drug/event, different patient
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Dyspepsia, Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: MODERATE TO SEVERE PAIN ON INJECTION SITE WITH REDNESS AND MODERATE SWELLING. PAIN INCREASED WITH ELEVATION OF EXTREMITY. COUGH STARTED ON 12/22/2020. MILD DYSPEPSIA.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Feeling cold, Injection site pain
Clinical narrative: chills, and cold , pain to injection site
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain, Pain in extremity
Clinical narrative: increased left upper arm soreness; mild injection site pain; This is a spontaneous report from a non-contactable consumer.  A 51-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 18Dec2020 15:30 at single dose for COVID-19 immunization.  The patient medical history was not reported.  The patient's concomitant medications were not reported.  The patient developed mild injection site pain that evening on 18Dec2020 and reported as increased left upper arm soreness on morning no limitation in movement on 19Dec2020. No other local/systemic events. Event took place after use of product. The outcome of the events was unknown.  No follow-up attempts are possible. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Oropharyngeal pain, Rhinorrhoea, SARS-CoV-2 test, Sneezing
Clinical narrative: Starting the evening of the 5th day after receiving the vaccine I noticed a sore, irritated throat. By the 7th day it was a more severe sore throat, runny nose, violent sneezes and the beginning of a deep painful cough. No fevers have been noted to date, with the highest oral temperature of 98.6F on the 7th day. I called the employee hotline, had a virtual visit with a Dr and took the drive up COVID test around 11:00 am on 12/23/20. I am in self quarantine currently awaiting results of the COVID test.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Throat irritation
Clinical narrative: Starting the evening of the 5th day after receiving the vaccine I noticed a sore, irritated throat. By the 7th day it was a more severe sore throat, runny nose, violent sneezes and the beginning of a deep painful cough. No fevers have been noted to date, with the highest oral temperature of 98.6F on the 7th day. I called the employee hotline, had a virtual visit with a Dr and took the drive up COVID test around 11:00 am on 12/23/20. I am in self quarantine currently awaiting results of the COVID test.
Sex: M
Vaccine: COVID19
Symptoms: Alcohol use, Vomiting
Clinical narrative: vomiting a lot; This is a spontaneous report from a Pfizer sponsored program . A non-contactable consumer (patient's partner) reported that a male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in Dec2020 at single dose for covid-19 immunisation.  The patient's medical history and concomitant medications were not reported. Caller's partner received the vaccine yesterday morning and drank a lot of alcohol in the evening. In Dec2020, her partner (patient) was vomiting a lot. She was worried if this was due to the vaccine and wanted to know what else could happen. Outcome of event was unknown.   No follow-up attempts are needed. Information about lot/batch number cannot be obtained.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Injection site pain, Rhinorrhoea, Sneezing
Clinical narrative: Moderna COVID-19 Vaccine EUA  pain in injection site, fatigue, sneezing, runny nose
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Flushing, Headache, Nasal congestion, Nausea, Pain
Clinical narrative: Nausea; have really bad runny nose; have really bad stuffy nose; I had a fever; I got flush rash, itchy rash kind of all over my body; I got flush rash, itchy rash kind of all over my body; Headache; This is a spontaneous report from a contactable Nurse (patient). A 32-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 18Dec2020 at single dose for COVID-19 immunization. The relevant medical history and concomitant medications were not reported. The patient stated that she got the first round of COVID vaccine the day prior the report and she was told to report her symptoms. She had a fever and got flush rash, itchy rash kind of all over her body and a headache on 18Dec2020. She took Tylenol Benadryl, it had helped with symptoms. At the time of the report morning she woke up with headache and she had really bad runny nose and stuffy nose and nausea on 19Dec2020. The outcome of the events was unknown.  Information on lot/batch number has been requested.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Rash pruritic, Rhinorrhoea
Clinical narrative: Nausea; have really bad runny nose; have really bad stuffy nose; I had a fever; I got flush rash, itchy rash kind of all over my body; I got flush rash, itchy rash kind of all over my body; Headache; This is a spontaneous report from a contactable Nurse (patient). A 32-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 18Dec2020 at single dose for COVID-19 immunization. The relevant medical history and concomitant medications were not reported. The patient stated that she got the first round of COVID vaccine the day prior the report and she was told to report her symptoms. She had a fever and got flush rash, itchy rash kind of all over her body and a headache on 18Dec2020. She took Tylenol Benadryl, it had helped with symptoms. At the time of the report morning she woke up with headache and she had really bad runny nose and stuffy nose and nausea on 19Dec2020. The outcome of the events was unknown.  Information on lot/batch number has been requested.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: After 15 min patient had tingling in her left arm all the way down to her hand, then started to travel to left side of face.  5 min later tingling started to travel to her left leg.  Pulse ox- 96% HR 57.  1251- ED lead RN was then contacted to evaluate patient in the ED.
Age: 0.08
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV5
Symptoms: Urticaria
Clinical narrative: Patient developed macular rash, which evolved into urticaria on face, torso, and extremities within 24 hours of vaccination.  She never developed anaphylaxis.  She was given antihistamines and the rash resolved within 1 week.  Parents are now vaccine hesitant.
Sex: U
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: Nauseous; This is a spontaneous report from a contactable consumer (patient).  A patient of unknown age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), at an unspecified dose via an unspecified route of administration, on 19Dec2020 at single dose for COVID-19 immunisation. Medical history and concomitant medications were unknown. The patient reported she got the vaccine yesterday (19Dec2020) and she is really nauseous right now (Dec2020). It was unknown if a treatment was received. Outcome was unknown. Information for Lot/Batch number has been requested.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site nodule, Pain, Pain in extremity
Clinical narrative: In the evening, the day I got the vaccine, I started feeling body aches all over. The arm that got the vaccine hurt the most, as to be expected, and there is a knot in the muscle where I got the injection. I have felt pain all over since then. It has not been touched by naproxen sodium. A cold shower gave temporary relief.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot
Clinical narrative: Patient complained of a rush of feeling very hot.   Patient was offered an ice pack for the back of her neck and was monitored until she felt better. Returned home following observation period.
Age: 38.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Lip swelling
Clinical narrative: My upper lip swell up, it is swollen, it is all swollen; This is a spontaneous report from a contactable consumer (patient). A 38-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EH9899) first dose on 16Dec2020 around 3 o'clock in the afternoon intramuscularly in left arm at single dose for COVID-19 immunization. Co-suspect product included mepyramine maleate, pamabrom, paracetamol (PAMPRIN) with unspecified date and dose for cramp. Medical history was none. Concomitant medication included sertraline. Patient took it on Wednesday (16Dec2020) around 3 O clock in the afternoon and then last night (18Dec2020) her upper lip of mouth swell up, it is swollen, it is all swollen. Patient worked in a hospital and they started the vaccination program for the employees and of course she wanted to take the shot and then she went in and took the shot. It was the first dose. Consumer stated she was completely healthy. Consumer further added last night she did take something for cramp it's called Pamprin, it's for, like when you have your period and you have like cramping, headache, back ache all of that, it's over the counter. For treatment for lip swell, Consumer stated No, just put ice on it. The action taken for mepyramine maleate, pamabrom, paracetamol was unknown. The outcome of the event was unknown.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Neck pain, Spinal pain
Clinical narrative: Severe neck and spine pain. No neurological symptoms noted but severe pain. Feels muscle related.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Headache, Pain
Clinical narrative: Body pain and headache, second day.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Limb discomfort, Malaise, Pyrexia
Clinical narrative: Fever; Chills; My arm was killing me; Not feeling well; This is a spontaneous report from a contactable consumer (patient). A 35-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number: EH9899) at single dose via unknown route of administration on 18Dec2020 for COVID-19 immunization. Medical history and concomitant medications were reported none. Consumer stated, she got the COVID vaccine yesterday (18Dec2020). And she woke up and she had fever and chills, and like her arm was killing her and it was just like she was not feeling well. So she was just wondering how long this was supposed to last. Due date for next shot was 08Jan2021. About the Indication, Consumer stated, Juts to get it she guessed. Because they worked at the hospital, they were providing it to all of them. Consumer stated, the adverse events probably started like around 4 O' clock this morning (19Dec2020). Consumer stated, she took some Ibuprofen as treatment. The outcome of the events was unknown.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia oral
Clinical narrative: Patient waited the mandatory 15 minutes and felt fine.  Left for a few minutes and then came back in to the vaccine clinic with symptoms of lips tingling and possible her tongue swelling.  She was given 50mg of PO Benadryl (Diphenhydramine) and was taken to the emergency department.  Patient was monitored for 4 hours in the emergency department with no additional symptoms noted.  Spoke with patient this morning, was still having some tingling of the lips but was being controlled with Benadryl.  No problems breathing or swallowing
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Headache; This is a spontaneous report from a contactable consumer (Patient). A 49-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EH9899, reported as BioNTech SARS-CoV-2) on right arm at single dose for covid-19 immunization. Medical history and concomitant drug were not reported. Patient stated a side effect to the vaccine (BioNTech SARS-CoV-2), she was just having the headache that won't go away. Treatment: consumer stated just took some over the counter Aspirin. Outcome of the event was not recovered.  Follow-up attempts have been completed and no further information is expected
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Headache, Oropharyngeal pain, Pain, SARS-CoV-2 test
Clinical narrative: Body aches, mild headache sore throat,mild cough. Started 12/20/20
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Burning sensation, Hypoaesthesia, Pain
Clinical narrative: ache all over, back pain, burning in thigh, numbness in foot
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Fatigue, Myalgia, Nausea
Clinical narrative: Upper body hives, Low grade fever 99.6, dizziness, weakness, tiredness, upper body muscle pain, nausea.  All lasting 24 hours+.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Urticaria
Clinical narrative: Upper body hives, Low grade fever 99.6, dizziness, weakness, tiredness, upper body muscle pain, nausea.  All lasting 24 hours+.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Balance disorder, Blood glucose normal, Headache, Nausea, Rhinorrhoea
Clinical narrative: "Equilibrium off", nausea, headache, and nasal drainage